Consensus Lundbeck Nasdaq Copenhagen

Equities

LUN

DK0061804697

Real-time Estimate Cboe Europe Other stock markets 04:30:20 2024-05-01 EDT			5-day change	1st Jan Change
29.2 ^DKK	-0.85%		+4.25%	-16.18%

04-09	H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy	MT
04-09	Lundbeck and Otsuka submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD	CI

Evolution of the average Target Price on Lundbeck

Price target over the last 5 years

History of analyst recommendation changes

a0156d4be03a7319122b554e14a10cf.fgx5wzWYpJc_mt3KdiLYpaASrnT1ppySLs0BPMJCtwg.OkktiAb57P14266_Ikav0fkh4Ru4zMSjRLVJdqcF2nwnQQGaUc7p32XCsg~e39ec89183b49b1b2bfaac5db2e8d844